Skip to main content

Grifols S.A. ADR(GRFS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines

PR Newswire - Tue Oct 19, 2021

BARCELONA, Spain, Oct. 19, 2021 /PRNewswire/ -- Grifols (MCE:GRF) (MCE:GRF.P) (NASDAQ:GRFS), one of the world's leading producers of plasma-derived medicines with a more than 110-year track record of contributing to the health and well-being of people around the world, and the National Service Projects Organization (NSPO) in Egypt today inaugurated the first integrated plasma-supply platform in Africa, the start of a robust plasma infrastructure that will bring self-sufficiency to Egypt while facilitating access to plasma products for the broader Middle East and African region, as well as other countries.

Innovative in its goals and scope, the alliance that Grifols and Egypt announced in November 2020 is the first ever that pairs a government entity and a private plasma manufacturer to tackle national self-sufficiency.  This game-changing initiative could be a blueprint for comparable efforts with other countries to increase local access to plasma and plasma treatments.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe